Honliv Healthcare Management Group Company Limited (HKG:9906)
1.640
0.00 (0.00%)
At close: Feb 13, 2026
HKG:9906 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 10.44 | 31.15 | 38.31 | 48.95 | 36.62 | 21.84 |
Depreciation & Amortization | 73.37 | 73.37 | 59.72 | 54.76 | 33.71 | 28.51 |
Other Amortization | 1.15 | 1.15 | 0.52 | - | - | - |
Loss (Gain) From Sale of Assets | -1.28 | -1.28 | 0.02 | 0.02 | 0.06 | 0 |
Asset Writedown & Restructuring Costs | - | - | - | 4.45 | - | - |
Provision & Write-off of Bad Debts | 0.53 | 0.53 | 15.29 | 1.96 | 0.09 | 4.61 |
Other Operating Activities | 49.56 | 5.53 | 8.74 | -1.99 | 17.44 | 32.19 |
Change in Accounts Receivable | -32.64 | -32.64 | 0.42 | -14.82 | -15.53 | -6.68 |
Change in Inventory | -7.72 | -7.72 | -2.35 | -2.36 | -6.43 | 2.42 |
Change in Accounts Payable | -23.58 | -23.58 | 22.74 | -4.18 | 10.54 | -19.46 |
Change in Other Net Operating Assets | 36.82 | 36.82 | -51.85 | 31.69 | 14.95 | 11.19 |
Operating Cash Flow | 106.66 | 83.34 | 91.56 | 118.47 | 91.44 | 74.61 |
Operating Cash Flow Growth | 4.06% | -8.97% | -22.72% | 29.56% | 22.56% | -13.29% |
Capital Expenditures | -37.58 | -49.67 | -89.25 | -18.91 | -51.02 | -80.43 |
Sale of Property, Plant & Equipment | 19.09 | - | - | - | - | - |
Sale (Purchase) of Intangibles | -1.67 | -2.49 | -0.3 | -0.9 | -0.34 | -0.42 |
Other Investing Activities | 0.77 | 0.77 | 0.79 | 0.65 | 0.9 | 0.79 |
Investing Cash Flow | -19.39 | -51.38 | -88.76 | -19.16 | -50.46 | -80.06 |
Long-Term Debt Issued | - | 156.75 | 182.98 | 164 | 187 | 213 |
Total Debt Issued | 124.15 | 156.75 | 182.98 | 164 | 187 | 213 |
Long-Term Debt Repaid | - | -161.47 | -148.53 | -211.19 | -248.92 | -239.45 |
Total Debt Repaid | -159.13 | -161.47 | -148.53 | -211.19 | -248.92 | -239.45 |
Net Debt Issued (Repaid) | -34.98 | -4.72 | 34.45 | -47.19 | -61.92 | -26.45 |
Issuance of Common Stock | - | - | - | - | - | 283.89 |
Repurchase of Common Stock | -17.44 | - | -45.92 | -61.31 | - | - |
Common Dividends Paid | - | - | - | - | - | -7.23 |
Other Financing Activities | -8.27 | -8.58 | -7.65 | -9.35 | -14.96 | -35.06 |
Financing Cash Flow | -60.68 | -13.3 | -19.12 | -117.85 | -76.87 | 215.16 |
Foreign Exchange Rate Adjustments | -0.01 | 0.08 | 0.84 | 10.17 | -2.98 | -11.83 |
Net Cash Flow | 26.58 | 18.74 | -15.48 | -8.37 | -38.87 | 197.88 |
Free Cash Flow | 69.07 | 33.67 | 2.31 | 99.56 | 40.42 | -5.82 |
Free Cash Flow Growth | 136.33% | 1360.15% | -97.68% | 146.30% | - | - |
Free Cash Flow Margin | 9.86% | 4.38% | 0.30% | 13.68% | 6.66% | -1.11% |
Free Cash Flow Per Share | 0.13 | 0.06 | 0.00 | 0.17 | 0.07 | -0.01 |
Cash Interest Paid | 8.27 | 8.58 | 7.65 | 9.35 | 14.96 | 20.97 |
Cash Income Tax Paid | 4.47 | 13.45 | 10.14 | 14.54 | 12.5 | 7.95 |
Levered Free Cash Flow | 43.35 | -4.18 | -12.78 | 86.61 | 15.23 | -28.93 |
Unlevered Free Cash Flow | 48.51 | 1.18 | -8 | 92.46 | 23.94 | -16.38 |
Change in Working Capital | -27.12 | -27.12 | -31.04 | 10.32 | 3.53 | -12.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.